Effects of Mutations of 3 Amino Acids on Hepatocellular Carcinoma

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Technology in Cancer Research and Treatment

• Publication date

  2015-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/1533034614547455PMID 25261068
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Analysis of Reverse Transcriptase Gene Mutations in the Hepatitis B Virus at a University Hospital in Korea

  2014cited by this paper
• Keratin 8 variants are associated with cryptogenic hepatitis

  2012cited by this paper
• The current endeavors to understand the pathogenesis of intractable liver diseases.

  2012cited by this paper
• Mutation in the mitochondrial translation elongation factor EFTs results in severe infantile liver failure.

  2012cited by this paper
• Fanconi- Bickel Syndrome: Mutation in An Indian Patient

  2012cited by this paper
• Prevention of hepatocellular carcinoma: a concise review of contemporary issues.

  2012cited by this paper
• BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy

  2012cited by this paper
• A possible predictive marker of progression for hepatocellular carcinoma.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma.

  2011cited by this paper
• Hepatocellular carcinoma with subcutaneous metastasis of the scalp

  2011influential reference
• HCV-related hepatocellular carcinoma: From chronic inflammation to cancer.

  2010cited by this paper
• A novel mutation in the biliverdin reductase‐A gene combined with liver cirrhosis results in hyperbiliverdinaemia (green jaundice)

  2009cited by this paper
• Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics

  2009cited by this paper
• p53 immunocytochemistry and TP53 gene mutations in patients with chronic hepatitis C virus (HCV) infection.

  2009cited by this paper
• Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

  2009cited by this paper
• Large-scale analysis of the genetic and epigenetic alterations in hepatocellular carcinoma from Southeast China.

  2008cited by this paper
• Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer.

  2008cited by this paper
• Identification of novel ATP7B gene mutations and their functional roles in Korean patients with Wilson disease

  2007cited by this paper
• Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.

  2007cited by this paper
• 249ser p53 mutation in the serum of black southern African patients with hepatocellular carcinoma.

  2005cited by this paper
• A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency

  2005cited by this paper
• Ser‐249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa

  2004cited by this paper
• Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients.

  2004cited by this paper
• CTNNB1 mutations and β‐catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1 †

  2001cited by this paper
• Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non‐alcoholic patients

  2001cited by this paper
• p53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India

  2000cited by this paper
• Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia.

  2000cited by this paper
• Aberrant transcripts of the cyclin-dependent kinase-associated protein phosphatase in hepatocellular carcinoma.

  2000cited by this paper
• P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India

  2000cited by this paper
• Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.

  2000cited by this paper
• Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia.

  2000cited by this paper
• Mutations at Vicinity of Catalytic Sites of Hepatitis C Virus NS3 Serine Protease Gene Isolated from Hepatocellular Carcinoma Tissue

  2000cited by this paper
• Beta-catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice.

  1999cited by this paper
• Molecular analysis and diagnosis in Japanese patients with Wilson’s disease

  1999cited by this paper
• CDKN2 Mutation Is Infrequent in German Hepatocellular Carcinoma

  1999cited by this paper
• P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.

  1996cited by this paper
• Fulminant hepatic failure: Summary of a workshop

  1995cited by this paper

• No citing papers are available for this paper.